Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses

Journal of Infectious Diseases

Volumn 194, Issue 1, 2006, Pages 61-70

  Zhou, Jianfang ^a,b   Law, Helen K W ^a,b   Cheung, Chung Yan ^a,b   Ng, Iris H Y ^a,b   Peiris, J S Malik ^a,b   Lau, Yu Lung ^a,b  

^a Faculty of Medicine   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ARTICLE; AVIAN INFLUENZA; CHICKEN; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; MACROPHAGE ACTIVATION; NEUTROPHIL; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN SECRETION; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ADULT; AGE FACTORS; ANIMALS; BIRDS; CELLS, CULTURED; CHEMOKINES; FETAL BLOOD; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MACROPHAGES; NUCLEOPROTEINS; RECEPTORS, CHEMOKINE; TIME FACTORS; UP-REGULATION; VIRUS REPLICATION;

EID: 33745216720     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/504690     Document Type: Article

References (47)

1. Mahalingam S, Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 1999; 77:469-75.
2. Maghazachi AA. Chemokines, G proteins and natural killer cells. Arch Immunol Ther Exp (Warsz) 2000; 48:65-72.
3. Glass WG, Rosenberg HF, Murphy PM. Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol 2003; 3:467-73.
4. Mahalingam S, Friedland JS, Heise MT, Rulli NE, Meanger J, Lidbury BA. Chemokines and viruses: friends or foes? Trends Microbiol 2003; 11:383-91.
5. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-86.
6. Fujisawa H, Tsuru S, Taniguchi M, Zinnaka Y, Nomoto K. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J Gen Virol 1987; 68(Pt 2):425-32.
7. Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol 2004; 76:886-95.
8. Salentin R, Gemsa D, Sprenger H, Kaufmann A. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection. J Leukoc Biol 2003; 74:252-9.
9. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617-9.
10. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12:171-80.
11. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45.
12. Hennet T, Ziltener HJ, Frei K, Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992; 149:932-9.
13. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-71.
14. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-85.
15. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-7.
16. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999; 354:916-7.
17. Chin PS, Hoffmann E, Webby R, et al. Molecular evolution of H6 influenza viruses from poultry in southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (HSN1)-like genes in poultry. J Virol 2002; 76:507-16.
18. Liu E, Law HK, Lau YL. Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br J Haematol 2004; 126:517-26.
19. Liu EM, Tu W, Law HKW, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol 2001; 113:240-6.
20. Tu W, Cheung PT, Lau YL. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J Immunol 2000; 165:1331-6.
21. Tu W, Cheung PT, Lau YL. IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr Res 1999; 46:748-54.
22. Tu W, Zhang DK, Cheung PT, Tsao SW, Lau YL. Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. Br J Haematol 1999; 104:785-94.
23. Zhou J, Law HKW, Cheung CY, et al. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J Infect Dis 2006; 193:945-53.
24. Hirst GK. Adsorption of influenza hemagglutinins and virus by red blood cells. J Exp Med 1942; 76:195-209.
25. Payment P, Trudel M. Isolation and identification of viruses. In: Payment P, Trudel M, eds. Methods and techniques in virology. New York: Marcel Dekker, 1993:19-38.
26. Law HK, Cheung CY, Ng HY, et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 2005; 106:2366-74.
27. Ip WK, Lau YL. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J Immunol 2004; 173:189-96.
28. Tyner JW, Uchida O, Kajiwara N, et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 2005; 11:1180-7.
29. Asensio VC, Campbell IL. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 1997; 71:7832-40.
30. Shirato K, Kimura T, Mizutani T, Kariwa H, Takashima I. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J Med Virol 2004; 74:507-13.
31. John AE, Berlin AA, Lukacs NW Respiratory syncytial virus induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation. Eur J Immunol 2003; 33:1677-85.
32. Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL. Semiquantitative analysis of intrahepatic CC-chemokine mRNAs in chronic hepatitis C. Mediators Inflamm 2004; 13:357-9.
33. Teruya-Feldstein J, Setsuda J, Yao X, et al. MIP-1 alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest 1999; 79:1583-90.
34. Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, Welliver RC Sr. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 2005; 75:282-9.
35. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995; 269:1583-5.
36. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol 2000; 165:2677-82.
37. Kaufmann A, Salentin R, Gemsa D, Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol 2001; 69:248-52.
38. Zylla D, Li Y, Bergenstal E, et al. CCR5 expression and beta-chemokine production during placental neonatal monocyte differentiation. Pediatr Res 2003; 53:853-8.
39. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000; 156:1951-9.
40. Su SB, Mukaida N, Wang J, Nomura H, Matsushima K. Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes. J Leukoc Biol 1996; 60:658-66.
41. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001; 12:313-35.
42. Bonville CA, Lau VK, DeLeon JM, et al. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol 2004; 78:7984-9.
43. Shalekoff S, Gray GE, Tiemessen CT. Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers. Clin Diagn Lab Immunol 2004; 11:229-34.
44. Lipatov AS, Andreansky S, Webby RJ, et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol 2005; 86:1121-30.
45. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004; 431:703-7.
46. Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005; 79:14933-44.
47. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437:889-93.